Tyra Biosciences
TYRA · NASDAQ
$20.47+$1.13 (+5.84%)TodayMarket closed ·
Prev close $19.34
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 8.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.6626 | -$0.69 | −4.1% |
| Q1 FY26 | -$0.6044 | -$0.64 | −5.9% |
| Q4 FY25 | -$0.5387 | -$0.57 | −5.8% |
| Q3 FY25 | -$0.5075 | -$0.50 | +1.5% |
| Q2 FY25 | -$0.5393 | -$0.47 | +12.9% |
| Q1 FY25 | -$0.4994 | -$0.47 | +5.9% |
| Q4 FY24 | -$0.4901 | -$0.43 | +12.3% |
| Q3 FY24 | -$0.4067 | -$0.41 | −0.8% |
Earnings calls
- Special Call - Tyra Biosciences, Inc.
- Bank of America Global Healthcare Conference 2026
- Special Call - Tyra Biosciences, Inc.
- BofA Securities 2025 Healthcare Conference
- Barclays 27th Annual Global Healthcare Conference 2025
- Special Call - Tyra Biosciences, Inc.
- Goldman Sachs 45th Annual Global Healthcare Conference
- Barclays 26th Annual Global Healthcare Conference 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.